Education
About Us
Working with TipRanks
Follow Us
ZimVie Inc (ZIMV)
NASDAQ:ZIMV
ZIMV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$10.75 - $22.40
Previous CloseN/A
Volume26.95K
Average Volume (3M)150.18K
Market Cap
$301.96M
Enterprise Value$542.62M
Total Cash (Recent Filing)$74.97M
Total Debt (Recent Filing)$232.57M
Price to Earnings (P/E)―
Beta1.63
Next Earnings
May 01, 2025EPS Estimate
0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.93
Shares Outstanding27,677,345
10 Day Avg. Volume137,365
30 Day Avg. Volume150,178
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.72
Price to Cash Flow (P/CF)3.80
P/FCF Ratio2.80
Enterprise Value/Market Cap1.80
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.89
Enterprise Value/Ebitda43.88
Forecast
1Y Price Target
$15.00Price Target Upside37.49% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering2
---
ZimVie Inc News
PremiumCompany Announcements
ZimVie Inc Announces Board Leadership Changes
PremiumCompany Announcements
ZimVie Inc. Earnings Call: Transformation and Growth
PremiumCompany Announcements
ZimVie Inc. Reports 2024 Financial Results
PremiumCompany Announcements
ZimVie Inc Reports 2024 Financial Results and Transformation
---
Bulls Say, Bears Say
Bulls Say
Manufacturing EfficiencyManufacturing efficiency initiatives resulted in strong sequential gross margin improvement.
Market ShareManagement believes it is gaining premium implant market share.
Bears Say
Product PerformanceImplants and scanners were the two weakest product groups in the quarter.
RevenueZIMV missed consensus revenue while adjusted EBITDA met expectations in 4Q24.
---
Ownership Overview
21.85% Insiders
19.91% Mutual Funds
0.24% Other Institutional Investors
42.98% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ZIMV FAQ
What was ZimVie Inc’s price range in the past 12 months?
ZimVie Inc lowest stock price was $10.74 and its highest was $22.40 in the past 12 months.
What is ZimVie Inc’s market cap?
ZimVie Inc’s market cap is $301.96M.
When is ZimVie Inc’s upcoming earnings report date?
ZimVie Inc’s upcoming earnings report date is May 01, 2025 which is in 29 days.
How were ZimVie Inc’s earnings last quarter?
ZimVie Inc released its earnings results on Feb 26, 2025. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.01.
Is ZimVie Inc overvalued?
According to Wall Street analysts ZimVie Inc’s price is currently Undervalued.
Does ZimVie Inc pay dividends?
ZimVie Inc does not currently pay dividends.
What is ZimVie Inc’s EPS estimate?
ZimVie Inc’s EPS estimate is 0.22.
How many shares outstanding does ZimVie Inc have?
ZimVie Inc has 27,677,345 shares outstanding.
What happened to ZimVie Inc’s price movement after its last earnings report?
ZimVie Inc reported an EPS of $0.27 in its last earnings report, beating expectations of $0.26. Following the earnings report the stock price went down -1.679%.
Which hedge fund is a major shareholder of ZimVie Inc?
Currently, no hedge funds are holding shares in ZIMV
---
ZimVie Inc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$15.00 (37.49% Upside)
$15.00 (37.49% Upside)
Blogger Sentiment
Bullish
ZIMV Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 97.2K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-33.83%
12-Months-Change
Fundamentals
Return on Equity
-8.53%
Trailing 12-Months
Asset Growth
-37.47%
Trailing 12-Months
Company Description
ZimVie Inc
ZimVie Inc (ZIMV) is a global medical technology company that operates primarily in the healthcare sector. The company specializes in the development, manufacturing, and marketing of a wide range of medical devices and solutions. ZimVie focuses on providing innovative products and services to improve patient care in areas such as dental and spine health. The company's offerings include dental implants, surgical instruments, and spinal solutions, aimed at enhancing clinical outcomes and patient experience.
---
ZIMV Company Deck
---
ZIMV Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
ZimVie had a transformative year with significant strategic shifts and financial improvements, particularly in cash flow and EBITDA margins. However, revenue decline and challenges in the implant market, especially in the specialist segment, present ongoing challenges.Read More>---
ZIMV Stock 12 Month Forecast
Average Price Target
$15.00
▲(37.49% Upside)
Technical Analysis
Best Analysts Covering ZIMV
1 Year
1 Year Success Rate
5/8 ratings generated profit
1 Year Average Return
-27.35%
reiterated a sell rating 2 months ago
Copying Matt Miksic's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of -27.35% per trade.
---